Martin Shkreli’s Latest Plan to Sharply Raise Drug Price Prompts Outcry

Saturday, December 12, 2015 - 09:30 in Mathematics & Economics

Critics say that Turing, the pharmaceutical led by Mr. Shkreli, is exploiting a program that awards vouchers that can be sold at huge profits while pricing drugs out of patients’ reach.

Read the whole article on NY Times Health

More from NY Times Health

Latest Science Newsletter

Get the latest and most popular science news articles of the week in your Inbox! It's free!

Check out our next project, Biology.Net